These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


426 related items for PubMed ID: 18512311

  • 1. [The immunophenotypic analysis of CD7+ and (or) CD56+ acute myeloid leukemic stem cells and its applications in minimal residual disease detection].
    Cao H, Wang YZ, Wu HH, Chang Y, Hao L, Chen SS, Huang XJ, Lu DP, Liu YR.
    Zhonghua Xue Ye Xue Za Zhi; 2008 Jan; 29(1):23-8. PubMed ID: 18512311
    [Abstract] [Full Text] [Related]

  • 2. [Analysis of immunophenotype and leukemia associated immunophenotype in 610 patients with acute myeloid leukemia].
    Liu YR, Wang YZ, Chen SS, Chang Y, Fu JY, Li LD, Wang H, Yu H, Jiang B, Huang XJ.
    Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):731-6. PubMed ID: 18457262
    [Abstract] [Full Text] [Related]

  • 3. [Expression of 5 genes in CD7 positive acute myeloid leukemia stem/progenitor cells from bone marrow].
    Wu HH, Cao H, Wang YZ, Wang DX, Lin HR, Qin YZ, Chang Y, Hao L, Li LD, Li JL, Ruan GR, Huang XJ, Liu YR.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Apr; 17(2):298-303. PubMed ID: 19379555
    [Abstract] [Full Text] [Related]

  • 4. Immunoprofiling of leukemic stem cells CD34+/CD38-/CD123+ delineate FLT3/ITD-positive clones.
    Al-Mawali A, Gillis D, Lewis I.
    J Hematol Oncol; 2016 Jul 27; 9(1):61. PubMed ID: 27465508
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. CD34+CD38-CD123+ Cells Are Present in Virtually All Acute Myeloid Leukaemia Blasts: A Promising Single Unique Phenotype for Minimal Residual Disease Detection.
    Al-Mawali A, Pinto AD, Al-Zadjali S.
    Acta Haematol; 2017 Jul 27; 138(3):175-181. PubMed ID: 29065396
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. MRD abnormal expression predict poor outcomes for refractory or relapsed acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation.
    Hao Q, Liu X, Zhang Y, Zhang D, Li B, Wang J.
    J Clin Lab Anal; 2021 Oct 27; 35(10):e23974. PubMed ID: 34432318
    [Abstract] [Full Text] [Related]

  • 10. [The immunophenotypic and clinical characteristics of NPM1 mutated acute myeloid leukemia patients].
    Liu YR, Chang Y, Ruan GR, Qin YZ, Lai YY, Shi HX, Wang YZ, Li LD, Jiang B, Li JL.
    Zhonghua Xue Ye Xue Za Zhi; 2013 Feb 27; 34(2):98-103. PubMed ID: 23611213
    [Abstract] [Full Text] [Related]

  • 11. Tracing Leukemia Stem Cells and Their Influence on Clinical Course of Adult Acute Myeloid Leukemia.
    Kandeel EZ, El Sharkawy N, Hanafi M, Samra M, Kamel A.
    Clin Lymphoma Myeloma Leuk; 2020 Jun 27; 20(6):383-393. PubMed ID: 32201129
    [Abstract] [Full Text] [Related]

  • 12. Identification of a small subpopulation of candidate leukemia-initiating cells in the side population of patients with acute myeloid leukemia.
    Moshaver B, van Rhenen A, Kelder A, van der Pol M, Terwijn M, Bachas C, Westra AH, Ossenkoppele GJ, Zweegman S, Schuurhuis GJ.
    Stem Cells; 2008 Dec 27; 26(12):3059-67. PubMed ID: 19096043
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Prognostic Impact and Phenotype of Residual Acute Myeloid Leukemia Stem Cells.
    Jaddaoui S, Bencharef H, Lamchahab M, Quessar A, Oukkache B.
    Clin Lab; 2022 Jun 01; 68(6):. PubMed ID: 35704721
    [Abstract] [Full Text] [Related]

  • 16. Differential antigen expression and aberrant signaling via PI3/AKT, MAP/ERK, JAK/STAT, and Wnt/β catenin pathways in Lin-/CD38-/CD34+ cells in acute myeloid leukemia.
    Garg S, Shanmukhaiah C, Marathe S, Mishra P, Babu Rao V, Ghosh K, Madkaikar M.
    Eur J Haematol; 2016 Mar 01; 96(3):309-17. PubMed ID: 26010294
    [Abstract] [Full Text] [Related]

  • 17. [Clinical significance for minimal residual disease detection by 4 color flow cytometry in adult and childhood B lineage acute lymphoblastic leukemia].
    Liu YR, Zhang LP, Chang Y, Cheng YF, Fu JY, Li LD, Wang H, Liu GL, Chen SS, Huang XJ, Lu DP.
    Zhonghua Xue Ye Xue Za Zhi; 2006 May 01; 27(5):302-5. PubMed ID: 16875577
    [Abstract] [Full Text] [Related]

  • 18. High proportion of leukemic stem cells at diagnosis is correlated with unfavorable prognosis in childhood acute myeloid leukemia.
    Witte KE, Ahlers J, Schäfer I, André M, Kerst G, Scheel-Walter HG, Schwarze CP, Pfeiffer M, Lang P, Handgretinger R, Ebinger M.
    Pediatr Hematol Oncol; 2011 Mar 01; 28(2):91-9. PubMed ID: 21214408
    [Abstract] [Full Text] [Related]

  • 19. Flow cytometric quantification and immunophenotyping of leukemic stem cells in acute myeloid leukemia.
    Hwang K, Park CJ, Jang S, Chi HS, Kim DY, Lee JH, Lee JH, Lee KH, Im HJ, Seo JJ.
    Ann Hematol; 2012 Oct 01; 91(10):1541-6. PubMed ID: 22669506
    [Abstract] [Full Text] [Related]

  • 20. [Immunologic characteristics and prognosis of acute myeloid leukemia M1].
    Zhao F, Chen Y.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug 01; 15(4):687-91. PubMed ID: 17708783
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.